EGFR and neoplasm: In particular, lung cancer is a prototype of precision oncology, and once a diagnosis of lung cancer is made, it is easier to develop effective treatment strategies using EGFR-TKI or anti-PD-1 antibodies as indicated by the tumor biomarkers.